Search

Your search keyword '"Valenzi, E"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Valenzi, E" Remove constraint Author: "Valenzi, E"
75 results on '"Valenzi, E"'

Search Results

2. OC.14.2: THE MANAGEMENT OF CHRONIC CONSTIPATION IN ITALY: RESULTS FROM A SURVEY CONDUCTED AMONG ITALIAN GASTROENTEROLOGISTS

3. Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis

4. 'Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.'

10. Integrating Gene Expression with Genome-Wide Association Summary Statistics to Identify Genes Associated with Idiopathic Pulmonary Fibrosis Survival

11. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

12. Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma.

13. S65 Genome-wide association study of survival times after diagnosis of idiopathic pulmonary fibrosis

16. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

26. Overpay Inequity or Self-Image as a Worker: A Critical Examination of an Experimental Induction Procedure.

34. Altered AP-1, RUNX and EGR chromatin dynamics drive fibrotic lung disease.

35. Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19.

36. The Diagnosis and Management of Chronic Constipation in Italy: Results from a Survey Conducted among Italian Gastroenterologists.

37. New systemic treatment options for advanced cholangiocarcinoma.

38. Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis-Associated and Idiopathic Pulmonary Hypertension.

39. Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis.

40. Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs.

41. "Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer."

42. Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosis.

43. LEF1 isoforms regulate cellular senescence and aging.

44. Impact of enzymatic digestion on single cell suspension yield from peripheral human lung tissue.

45. Usual interstitial pneumonia is the predominant histopathology in patients with systemic sclerosis receiving a lung transplant.

46. Single-nucleus chromatin accessibility identifies a critical role for TWIST1 in idiopathic pulmonary fibrosis myofibroblast activity.

47. PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.

48. Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.

49. Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?

50. Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.

Catalog

Books, media, physical & digital resources